Clinically Relevant OATP2B1 Inhibitors in Marketed Drug Space

Unger, Melissa S.; Mudunuru, Jennypher; Schwab, Matthias; Hopf, Carsten; Drewes, Gerard; Nies, Anne T.; Zamek-Gliszczynski, Maciej J.; Reinhard, Friedrich B. M.

dc.contributor.author	Schwab, Matthias
dc.contributor.author	Nies, Anne
dc.date.accessioned	2020-10-20T08:12:36Z
dc.date.available	2020-10-20T08:12:36Z
dc.date.issued	2020
dc.identifier.issn	1543-8384
dc.identifier.uri	http://hdl.handle.net/10900/108077
dc.language.iso	en	de_DE
dc.publisher	Amer Chemical Soc	de_DE
dc.relation.uri	http://dx.doi.org/10.1021/acs.molpharmaceut.9b00897	de_DE
dc.subject.ddc	610	de_DE
dc.title	Clinically Relevant OATP2B1 Inhibitors in Marketed Drug Space	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_01851
utue.publikation.seiten	488-498	de_DE
utue.personen.roh	Unger, Melissa S.
utue.personen.roh	Mudunuru, Jennypher
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Hopf, Carsten
utue.personen.roh	Drewes, Gerard
utue.personen.roh	Nies, Anne T.
utue.personen.roh	Zamek-Gliszczynski, Maciej J.
utue.personen.roh	Reinhard, Friedrich B. M.
dcterms.isPartOf.ZSTitelID	Molecular Pharmaceutics	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	17	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE